-- Artemis Gold Brief: National Bank Maintaining Outperform and C$40.50 Target After Co Announced $700 Million RCF and PLF Repaid-March 2024-www.financetom.com

Business

-- Artemis Gold Brief: National Bank Maintaining Outperform and C$40.50 Target After Co Announced $700 Million RCF and PLF Repaid

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

-- Artemis Gold Brief: National Bank Maintaining Outperform and C$40.50 Target After Co Announced $700 Million RCF and PLF Repaid

Sep 29, 2025 8:44 AM

11:15 AM EDT, 09/29/2025 (MT Newswires) --

Price: 35.70, Change: +0.80, Percent Change: +2.29

Previous page： Viasat Gets $33.6 Million Antenna Technology Development Contract From US Air Force Next page： Sabre, Google Work on Pilot Program to Reduce Business Travel Environmental Impact

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Viasat Gets $33.6 Million Antenna Technology Development Contract From US Air Force

Sep 24, 2024

10:53 AM EDT, 09/24/2024 (MT Newswires) -- Viasat ( VSAT ) said Tuesday it has been awarded a $33.6 million contract to provide Active Electronically Scanned Array systems for the US Air Force. Under the deal, the company said it will develop a new phased array antenna that can support resilient satellite communications for tactical aircraft. Shares of Viasat (...

Sabre, Google Work on Pilot Program to Reduce Business Travel Environmental Impact

Sep 24, 2024

10:55 AM EDT, 09/24/2024 (MT Newswires) -- Sabre (SABR) and Alphabet's (GOOG, GOOGL) Google ( GOOG ) said Tuesday they are working on a pilot program aimed at reducing the environmental impact of business travel. Under the program, Google ( GOOG ) analysts are using Google's ( GOOG ) Travel Impact Model and Sabre's business travel data from last year...

Silexion Therapeutics Says its Pancreatic Cancer Drug, Loder, Improves Tumor Resectability; Shares Rises

Sep 24, 2024

08:51 AM EDT, 09/24/2024 (MT Newswires) -- Silexion Therapeutics ( SLXN ) said Tuesday patients with non-resectable locally advanced pancreatic cancer whose pancreatic cancer tumors became resectable had a 67% objective response rate in a phase 2 trial of its experimental drug Loder. The trial showed an overall 56% objective response rate among patients with non-resectable locally advanced pancreatic cancer....

Sector Update: Consumer

Sep 24, 2024

08:52 AM EDT, 09/24/2024 (MT Newswires) -- Consumer stocks were flat to higher premarket Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) inactive and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.2%. Maison Solutions ( MSS ) shares were up past 111% after the company reported that it swung to fiscal Q1 net income as sales...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP